677200

Stason Pharmaceuticals, Inc. — FEI 1000160561

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 24, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Irvine, CA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
683021 CFR 314.80(c)(2)Interval